Jelmar presents at Biomarker and Companion Diagnostics Conference

Last week Jelmar Quist presented at the Markets & Markets 4th Annual Biomarker and Companion Diagnostics Conference. The conference aims to “address the gaps between early-stage biomarker development and the commercialization stage of biomarkers”.

Jelmar spoke on Bioinformatics approaches for classification of breast cancers, covering the following topics:

  • Integration of transcriptomics and genomics data can reveal convergent pathway
    dependencies with a potential for therapeutic intervention.
  • Classification of high-dimensional mixed-type data can be achieved through a permutation-
    based framework for random forest.
  • Extensive qualitative and quantitative evaluation of clusters could ultimately aid patient

Scroll to Top